Royal Philips NV Sponsored ADR Stock

$27.06

1.89%

NYSE, Sep 02, 10:00 pm CET

ISIN

US5004723038

Symbol

PHG

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Overview Dividends Analysts Charts News Strategies

Royal Philips NV Sponsored ADR Stock price

$27.06

-18.19 40.20% 5Y

NYSE, Closing price Tue, Sep 02 2025

-0.52 1.89%

ISIN

US5004723038

Symbol

PHG

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Key metrics

Basic

Market capitalization

$26.1b

Enterprise Value

$33.8b

Net debt

$7.7b

Cash

$2.1b

Shares outstanding

950.6m

Valuation (TTM | estimate)

P/E

135.3 | 16.6

P/S

1.3 | 1.2

EV/Sales

1.6 | 1.6

EV/FCF

66.9

P/B

2.2

Dividends

DPS

$0.97

Yield 1Y | 5Y

3.6% | 1.8%

Growth 1Y | 5Y

100.0% | -

Payout 1Y | 3Y

-111.2% | -28.4%

Increased

1 Year

Financials (TTM | estimate)

Revenue

$20.8b | $21.2b

EBITDA

$2.8b | $3.4b

EBIT

$1.3b | $2.2b

Net Income

$188.6m | $1.6b

Free Cash Flow

$505.2m

Growth (TTM | estimate)

Revenue

-1.5% | 1.1%

EBITDA

140.0% | 25.2%

EBIT

476.2% | 99.3%

Net Income

138.5% | 289.8%

Free Cash Flow

-61.8%

Financial Health

Equity Ratio

41.4%

Return on Equity

-5.9%

ROCE

5.7%

ROIC

1.1%

Debt/Equity

0.8

EPS

$0.2

FCF per Share

$0.5

Short interest

0.1%

Employees

67k

Rev per Employee

$310.0k

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Get Started for Free Today

Royal Philips NV Sponsored ADR Stock Analysis

Unlock Scores for Free

??

26 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

15x Buy

58%

11x Hold

42%

More details on Analyst Estimates Including Price Targets

26 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

Buy

58%

Hold

42%

Analyst Estimates with Stock Price Targets

Financial data from Royal Philips NV Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	20,787 20,787	2% 2% 100%
- Direct Costs	11,673 11,673	5% 5% 56%
Gross Profit	9,114 9,114	4% 4% 44%
- Selling and Administrative Expenses	5,865 5,865	2% 2% 28%
- Research and Development Expense	2,054 2,054	2% 2% 10%
EBITDA	2,778 2,778	140% 140% 13%
- Depreciation and Amortization	1,508 1,508	1% 1% 7%
EBIT (Operating Income) EBIT	1,270 1,270	476% 476% 6%
Net Profit	189 189	138% 138% 1%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Royal Philips NV Sponsored ADR Stock News

Neutral

GlobeNewsWire

●

7 days ago

Philips launches Transcend Plus for EPIQ CVx and Affiniti CVx, delivering breakthrough image quality and FDA-cleared AI enhancements in cardiovascular ultrasound

August 27, 2025 Next-generation 2D and 3D imaging and intelligent automation empower clinicians to make faster, more confident decisions in cardiac care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the release of Transcend Plus, the next generation its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems. Transc...

Neutral

PRNewsWire

●

9 days ago

Philips Norelco launches Head Shaver Pro series, featuring elevated comfort and precision

The No. 1 electric shave brand* brings its unmatched blade technology to a new grooming category, helping deliver a smoother, more personalized headshave experience CAMBRIDGE, Mass. , Aug. 25, 2025 /PRNewswire/ -- Today Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and grooming innovation, announces the launch of Philips Norelco Head Shaver Pro Series — a breakthrou...

Neutral

PRNewsWire

●

14 days ago

It's Not Me, It's You: An Official Breakup Letter to My Old Hair Removal Routine

CAMBRIDGE, Mass. , Aug.

More Royal Philips NV Sponsored ADR News

Company Profile

Royal Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Head office	Netherlands
CEO	Roy Jakobs
Employees	66,678
Founded	1891
Website	www.philips.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now